BRIEF — Taisho seeks to increase Duoc Hau Giang share

Japanese drugmaker Taisho Pharmaceutical has sought to increase its stake in Vietnam-based Duoc Hau Giang Pharmaceutical JSC beyond the current 35% share.

Taisho’s board resolved this week to make a tender offer targeting a further 21.7% as part of its focus on investments in global markets, especially Southeast Asia.

The cost of buying the new shares will come to around 16 billion Japanese yen ($150 million), though the deal will have to be approved by the Vietnamese authorities.